Researchers at the University of Colorado Anschutz enrolled the first patient in a clinical trial testing a combination therapy for central auditory processing disorder (CAPD). In animal models, it produced a near-complete reversal of the condition within 30 days.
Why it matters
Central auditory processing disorder (CAPD) affects 800 million people worldwide and has no FDA-approved treatments. The 2024 Lancet Commission on Dementia Prevention identified untreated hearing loss as the largest modifiable risk factor for dementia. This trial is the first serious attempt to fix the problem.
“If somebody has hearing loss and it’s untreated, they’re at higher risk for not just dementia, but also Alzheimer’s, depression and a lot of other mental health diseases.” —Achim Klug, PhD, professor of physiology and biophysics at the [Anschutz School of Medicine](CU Anschutz Launches Clinical Trial for CAPD Therapy That Reversed Hearing Loss in Models)
The problem
Most people think hearing loss is in the ear. It isn't.
- CAPD is a brain circuit failure, not an ear failure.
- Myelin, the fatty insulation around nerve fibers, degrades with age.
- When it does, auditory signals lose fidelity before your brain can process them.
- Hearing aids amplify sound but don't repair the circuitry.
Everybody knows about hearing loss at the level of the ear, and that’s when you need a hearing aid. But there is a brain attached to the ear that processes all that information. Older people have a lot of trouble in the crowded-restaurant scenario, and it’s not because they need a hearing aid. It’s because the brain circuits have changed, and they don’t process that information as effectively as young people do. So that’s what we’re aiming to treat.” —Dr. Klug
How it works
The [therapy](CU Anschutz Launches Clinical Trial for CAPD Therapy That Reversed Hearing Loss in Models) pairs two components that do nothing alone but everything together.
- Clemastine fumarate, an antihistamine from the 1960s, crosses the blood-brain barrier and tells stem cells to produce oligodendrocytes, the cells that rebuild myelin. These stem cells need a signal to know which circuit to repair.
- Patients wear headphones for one hour a day for 30 days, listening to a background sound designed to fire the damaged auditory circuit. This activity guides the stem cells to the correct location, and Clemastine rebuilds myelin.
In preclinical models, the combination treatment was the only one that worked. Dr. Klug describes the result: "basically complete recovery."
By the numbers:
- 344 maximum trial participants.
- Ages 45–65 can enroll.
- 4 treatment combinations: placebo/placebo, drug only, sound only, and combination.
- 229 days from FDA submission to first patient enrolled.
- 1 in 12 dementia cases are potentially preventable with adequate hearing treatment.
A closer look
The age profile is younger than expected. Klug's lab expected CAPD to affect those 60 and older. They're now fielding questionnaires from people in their 30s, including a 21-year-old.
The same demyelination pattern appears in autism research in the same brain region. Klug says a future trial targeting that population is an "obvious question" his lab wants to answer.
Reality check
All results so far come from animal models. No human efficacy data exists yet. The trial is Phase I/II, meaning safety and dosing are still being worked out alongside early efficacy signals.
The bottom line
If the combination works, a $10 antihistamine and headphones could become the first treatment to reverse brain-related hearing loss.
Protect and preserve your hearing
Hearing loss doesn't mean losing your balance, social world, or increasing your risk of dementia. Our free 15-minute hearing screening will help you:
- Understand your current hearing health
- Prevent communication barriers
- Stay engaged with loved ones
- Maintain your quality of life
Schedule your free screening today and rediscover the sounds that matter most.
★ Call 708-599-9500 to schedule your free screening.
★ For facts about hearing loss and hearing aid options, grab your copy of The Hearing Loss Guide.
★ Sign up for our newsletter for the latest on Hearing aids, dementia triggered by hearing loss, pediatric speech and hearing, speech-language therapies, Parkinson's Voice therapies, and occupational-hearing conservation. We publish our newsletter eight times a year.
Don't let untreated hearing loss spoil your enjoyment of life.
Crest Hill, IL - 630-633-5060 | Palos Hills, IL - 708-599-9500
